CHANNELS

Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Research and Markets: Global Influenza A And B Infections Therapeutics Pipeline Review, H1 2014: 5 Companies & 6 Drug Profiles

[May 15, 2014]

Research and Markets: Global Influenza A And B Infections Therapeutics Pipeline Review, H1 2014: 5 Companies & 6 Drug Profiles

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/8hn5q7/influenza_a_and_b) has announced the addition of the "Influenza A And B Infections - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Influenza A And B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Influenza A And B Infections and special features on late-stage and discontinued projects.

Scope

    The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Influenza A And B Infections and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Influenza A And B Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Influenza A And B Infections pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Companies Involved in Therapeutics Development

  • Toyama Chemical Co., Ltd.
  • Crucell N.V.
  • Cocrystal Discovery, Inc.
  • Beech Tree Labs, I;nc.
  • MI.TO. Technology S.r.L.

Drug Profiles

  • favipiravir
  • BTL-TML001
  • CR-9114
  • Small Molecules For Influenza
  • Monoclonal Antibody to Inhibit Hemagglutinin for Influenza A and B Virus Infection
  • Small Molecules For Influenza Virus Infection

For more information visit http://www.researchandmarkets.com/research/8hn5q7/influenza_a_and_b


[ InfoTech Spotlight's Homepage ]


blog comments powered by Disqus

FOLLOW US

Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter